Wiken TH, Hoivik ML, Buer L, Warren DJ, et al. Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring. Scand J Gastroenterol 2023 Feb 17:1-11. doi: 10.1080/00365521.2023.2176252.
PMID: 36799155